Associations of serum low-density lipoprotein and systolic blood pressure levels with type 2 diabetic patients with and without peripheral neuropathy: systemic review, meta-analysis and meta-regression analysis of observational studies

Naqvi, Syed Shah Zaman Haider; Imani, Saber; Hosseinifard, Hossein; Wen, Qing-Lian; Shahzad, M. Naveed; Ijaz, Iqra; Deng, Youcai; Guo, Man; Xu, Yong

doi:10.1186/s12902-019-0453-5

Table 1 Demographics information of included studies

From: Associations of serum low-density lipoprotein and systolic blood pressure levels with type 2 diabetic patients with and without peripheral neuropathy: systemic review, meta-analysis and meta-regression analysis of observational studies

First author (Ref.)	Year	SS	Gender (M/F)	Mean Duration of DM (Months)	Population (ethnicity)	Study design	NOS^a
Zhao W. et al. [4]	2016	469	283/186	120	China (A)	Cross-sectional	8
Wu F. et al. [5]	2017	1134	645/489	78	China (A)	Cross-sectional	8
ALMA R. et al. [6]	2014	82	52/30	99.6	Canada (AM)	Case control	8
Yang J. et al. [7]	2017	1511	743/768	105	China/A	Cross-sectional	8
Bilir B. et al. [8]	2016	99	47/52	NA	Turkey/A	Clinical study	7
Sharon L. et al. [9]	2017	1981	1001/980	144	Singapore/A	Cross-sectional	8
Yong J. et al. [10]	2015	180	96/84	135.6	China/A	Case control	8
Su J. et al. [11]	2018	563	299/264	67.2	China/A	Cross-sectional	8
Zhang Y. et al. [12]	2017	1059	589/470	102.7	China/A	Case control	7
Won J. et al. [13]	2012	3999	1939/2060	121.2	Korea/A	Cross-sectional	7
Lin X. et al. [53]	2017	200	123/77	109	China/A	Cross-sectional	8
Qiao X. et al. [54]	2017	185	79/106	123	China/A	Cross-sectional	8
Sadosky A. et al. [34]	2014	323,378	151,927/171451	NA	USA/NA	Retrospective	8
YM. S. et al. [55]	2018	982	497/485	64	China/A	Cross-sectional	7
Khawaja N. et al. [56]	2018	1003	480/523	120	Jordan/A	Cross-sectional	7
Zhang Q. et al. [57]	2018	254	127/127	138	China/A	Case control	8
Jangh M. et al. [58]	2006	810	289/521	98.4	Iran/A	Cross-sectional	8
Kim S. et al. [59]	2013	1338	593/745	145	Korea/A	Cross-sectional	8
Bansal D. et al. [14]	2014	2006	989/1017	104.4	India/A	Cross-sectional	8
Buraczy M. et al. [15]	2016	1244	594/650	153.6	Poland/EU	Case control	8
Luo Y. et al. [16]	2015	412	233/179	150	China/A	Cross-sectional	7
Ren Z. et al. [17]	2015	787	395/392	179.4	China/A	Case control	8
Andersen S. et al. [44]	2018	1256	735/521	156	Denmark/EU	Cohort study	7
Anastasi T. et al. [45]	2017	381	220/161	147	Greece/EU	Cross-sectional	8
Xu T. et al. [46]	2017	537	161/376	NA	China/A	Observational	8
Zhu T. et al. [52]	2014	64	31/33	NA	China/A	Cross-sectional	8
Deng W. et al. [51]	2014	202	115/87	98	China/A	Cross-sectional	8
Thainá R. et al. [50]	2018	426	162/264	92	Brazil/SA	Cohort study	7
Miric D. et al. [35]	2016	80	33/47	72	Serbia/EU	Case control	7
Hussain G. et al. [42]	2013	86	38/48	96	India/A	Cross-sectional	7
Li L. et al. [43]	2014	3359	1607/1268	91	China/A	Cross-sectional	8
Pai Y. et al. [36]	2018	2837	1661/1186	130.4	Taiwan/A	Cross-sectional	7
Xu F. et al. [48]	2014	90	46/44	66	China/A	Cross-sectional	8
Wang H. et al. [37]	2013	207	88/119	NA	China/A	Case control	7
Wang H. et al. [40]	2012	261	124/137	76.9	China/A	Case control	8
Pai Y. et al. [39]	2018	626	333/293	184.8	Taiwan/A	Case control	8
Mao F. et al. [22]	2018	950	555/395	106.2	China/A	Cross-sectional	8
Hoque S. et al. [33]	2016	400	166/234	72	Bangladesh/A	Cross-sectional	8

Abbreviations: Ref. reference, SS sample size, M male, F femal, AM amaricen, A Asian, EU europea, NOS Newcastle-Ottawa scale, NA not avalibale
^aThe quality of non-randomized studies will be appraised using the Newcastle-Ottawa scale (NOS), categorized into three groups: the selection of the study groups; the comparability of the groups; as well as the ascertainment of either the exposure or outcome of interest for case-control or cohort studies respectively

Back to article page

ISSN: 1472-6823

Contact us

General enquiries: journalsubmissions@springernature.com

BMC Endocrine Disorders

Contact us